Dudediligence.

Aktis Oncology, Inc

AKTSNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.4MMar ’25$3.2MMar ’26$3.4MJun ’26
Net income, by quarter
−$15.0MMar ’25−$18.3MMar ’26−$24.1MJun ’26